drugset / Trial / NCT04542681
MANP in African Americans With Hypertension
Non-randomizedSequentialOpen-labelTreatment
Summary
Evaluate the cardiovascular properties of MANP in AA with Hypertension
Timeline
- Start
- 2018-05-01
- Primary completion
- 2022-12-30
- Completion
- 2023-06-30
Outcome
Outcome not reported
Stopped: “Study was withdrawn and replaced by a larger study”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | MANP | Unknown | 2.5 ug/kg | Subcutaneous |
| Comparator | MANP | Unknown | 5 ug/kg | Subcutaneous |